Legence Corp. LGN
52.52
0.07
0.13%
as of 25 Sep
- Market cap
- $5.7B
- P/E
- 0.0×
Follow LGN
| Dec '25 | Dec '24 | Dec '23 | |
|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 |
P/S ratio |
1.00 | 0.00 | 0.00 |
P/FCF ratio |
11.65 | 0.00 | 0.00 |
P/Operating CF |
26.97 | 0.00 | 0.00 |
P/B ratio |
3.24 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 |
EV/Sales |
1.24 | 0.00 | 0.00 |
EV/EBITDA |
15.44 | 0.00 | 0.00 |
EV/Operating CF |
12.28 | 16.64 | 16.64 |
EV/FCF |
14.38 | 25.86 | 25.86 |
Quick Ratio |
1.15 | 1.29 | — |
Current Ratio |
1.57 | 1.84 | — |
Net Debt/EBITDA |
2.93 | 7.49 | 0.00 |
Debt/Assets |
30.94% | 68.39% | 0.00% |
Debt/Equity |
1.05 | 7.90 | 0.00 |
Asset Turnover |
1.01 | 1.78 | 0.00 |
Operating CF/Net income |
(4.30) | (1.02) | (0.74) |
Capex/Depreciation |
(0.26) | (0.14) | (0.16) |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| (12.05%) | 0.00% | 0.00% | |
| (2.38%) | (2.43%) | 0.00% | |
ROIC |
2.77% | 2.54% | 0.00% |
Return on Tangible Assets |
(12.09%) | (6.82%) | 0.00% |
Average Days of Receivables |
83.58 | 78.02 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
13.43% | 11.57% | 11.52% |
Intangible Assets out of Total Assets |
0.49 | 0.60 | 0.00 |
Share Based Compensation of Revenue |
2.65% | 0.26% | 0.62% |
Graham Net Nets |
(0.31) | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 |
Earnings Yield |
(0.79%) | (0.79%) | (0.79%) |
Free Cash Flow Yield |
8.58% | 0.00% | 0.00% |
Revenue per Share |
42.95 | 0.00 | 0.00 |
Operating CF per Share |
4.33 | 0.00 | 0.00 |
Capex per Share |
(0.63) | 0.00 | 0.00 |
Free Cash Flow per Share |
3.69 | 0.00 | 0.00 |
Cash per Share |
3.88 | 0.00 | — |
Shareholders Equity per Share |
13.28 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | — |
Book value per Share |
13.28 | 0.00 | 0.00 |
Free Cash Flow |
219.32 | 10.53 | 17.20 |
Working Capital |
402.19 | 345.31 | — |
Capital Expenditures |
(37.55) | (18.74) | (16.72) |
Net Current Asset Value |
(780.25) | (1,392.49) | 0.00 |
EV/EBIT |
51.23 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.01 | 0.01 |
Net Profit Margin |
(2.34%) | (1.36%) | (2.85%) |
Price to Operating Income |
41.50 | 0.00 | 0.00 |
| Other line items | |||
Depreciation/Fixed assets |
1.55 | 1.82 | 0.00 |
Cash ROIC |
8.90% | (2.33%) | 0.00% |
Accounts Receivable Turnover |
4.94 | 0.00 | 0.00 |
Accounts Payable Turnover |
10.81 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 |
Average Days of Payables |
44.60 | 27.68 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 |
Average Receivables |
516.34 | — | — |
Average Payables |
186.33 | — | — |
Average Assets |
2,515.95 | 1,176.25 | — |
Average Common Equity |
496.19 | — | — |
Columns are period end dates